Clinical Trials for CStone Pharmaceuticals

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: CStone Pharmaceuticals

Clinical Trials (6)

NCT05700448
Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma
PHASE3Not yet recruiting
150 participants
Started: Dec 31, 2025 · Completed: Jun 30, 2029
1 condition1 sponsor0 locations
NCT06741644
A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
660 participants
Started: Feb 24, 2025 · Completed: Jan 31, 2028
1 condition1 sponsor22 locations
NCT05297890
A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer
PHASE2Active, not recruiting
70 participants
Started: May 27, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors31 locations
NCT05279300
A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas
PHASE1Recruiting
480 participants
Started: Mar 28, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor38 locations
NCT04194775
A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma
PHASE3Active, not recruiting
534 participants
Started: Dec 13, 2019 · Completed: Oct 31, 2025
1 condition1 sponsor74 locations
NCT03789604
A Study of CS1001 in Subjects With Stage IV Non-Small Cell Lung Cancer
PHASE3Active, not recruiting
479 participants
Started: Dec 13, 2018 · Completed: Jun 30, 2027
1 condition1 sponsor1 location